Acute Myeloid Leukaemia (AML): Symptoms, Diagnosis and Treatment


Irvin Mendez (Editor)

Series: Cancer Etiology, Diagnosis and Treatments
BISAC: MED062000

Acute myeloid leukemia is the most common adult acute leukemia, but its etiology in individual patients is poorly understood. An increased risk of acute myeloid leukemia may be inherited (through congenital hematologic diseases and syndromes or germline disorders) or be acquired due to a lifetime of exposure to environmental or chemical agents, or genotoxic stress. In this collection, the authors explore risk factors for acute myeloid leukemia, newer epidemiologic studies on the connections between these risks and clinical phenotypes and outcomes of the disease.

The subsequent chapter evaluates different prognostic factors and stratifications of risk that have been published in an attempt to assess the influence of acute myeloid leukemia progression on the overall survival of myelodysplastic syndromes patients, evaluating them in a population-based registry.

Many acute myeloid leukemia patients cannot tolerate standard chemotherapy due to its high toxicity. A milder therapy for acute myeloid leukemia has long been sought after, and until now the only successful clinical application has been all-trans-retinoic acid-based therapy for just one subtype of acute myeloid leukemia, acute promyelocytic leukaemia. The concluding chapter aims to address other therapeutic candidates.

Table of Contents

Table of Contents


Chapter 1. Epidemiology of Acute Myeloid Leukemia
(Laura Finn, MD, Dipen Patel, MD, Ryan Griffin, MD, James M. Foran, MD, Ochsner Clinic Foundation, Department of Medicine, New Orleans, LA, US)

Chapter 2. Influence of Acute Myeloid Leukemia Progression on the Prognosis of Patients with Myelodysplastic Syndromes
(Alicia Enrico, MD, Jacqueline Gonzalez, MD2, Yesica Bestach, PhD, Ana Lisa Basquiera, PhD, Laura Kornblihtt, PhD, Graciela Alfonso, MD, Carolina Lazzarino, MD, Irene Larripa, PhD, Jorge Arbelbide, MD, and Carolina B. Belli, PhD, Servicio de Hematología, Hospital Italiano de La Plata, Argentina, and others)

Chapter 3. Experimental Premises for Differentiation Therapy of Acute Myeloid Leukaemia
(Ewa Marcinkowska, MD, PhD, and Geoffrey Brown, PhD, Laboratory of Protein Biochemistry, Faculty of Biotechnology, University of Wroclaw, Poland, and others)


Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!